Literature DB >> 8321432

Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists.

S A Daly1, J L Waddington.   

Abstract

The putative D-3 dopamine receptor agonist 7-OH-DPAT (10 micrograms/kg, s.c.) reduced spontaneous activity in rats, without inducing yawning; higher doses (0.1-10.0 mg/kg, s.c.) stimulated non-stereotyped sniffing, locomotion and chewing, which were attenuated by the selective D-1 antagonist BW 737C (5.0 mg/kg, s.c.) without release of any atypical behaviours. Low doses of 7-OH-DPAT may act on inhibitory D-3 receptors, while higher doses may act at stimulatory D-3 or other "D-2-like" receptors that participate in cooperative but not oppositional interactions with D-1 receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8321432     DOI: 10.1016/0028-3908(93)90177-5

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  25 in total

Review 1.  The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.

Authors:  Christian A Heidbreder; Eliot L Gardner; Zheng-Xiong Xi; Panayotis K Thanos; Manolo Mugnaini; Jim J Hagan; Charles R Ashby
Journal:  Brain Res Brain Res Rev       Date:  2005-07

2.  Effects of dopamine D3 preferring compounds on conditioned place preference and intracranial self-stimulation in the rat.

Authors:  T Kling-Petersen; E Ljung; L Wollter; K Svensson
Journal:  J Neural Transm Gen Sect       Date:  1995

3.  Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning.

Authors:  T V Khroyan; D A Baker; J L Neisewander
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

4.  Blonanserin ameliorates phencyclidine-induced visual-recognition memory deficits: the complex mechanism of blonanserin action involving D₃-5-HT₂A and D₁-NMDA receptors in the mPFC.

Authors:  Hirotake Hida; Akihiro Mouri; Kentaro Mori; Yurie Matsumoto; Takeshi Seki; Masayuki Taniguchi; Kiyofumi Yamada; Kunihiro Iwamoto; Norio Ozaki; Toshitaka Nabeshima; Yukihiro Noda
Journal:  Neuropsychopharmacology       Date:  2014-08-14       Impact factor: 7.853

5.  Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.

Authors:  Gregory T Collins; Jeffrey M Witkin; Amy H Newman; Kjell A Svensson; Peter Grundt; Jianjing Cao; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2005-04-15       Impact factor: 4.030

6.  The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity.

Authors:  N Waters; K Svensson; S R Haadsma-Svensson; M W Smith; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1993

7.  NMDA or AMPA/kainate receptor blockade prevents acquisition of conditioned place preference induced by D(2/3) dopamine receptor stimulation in rats.

Authors:  Anna-Maria Biondo; Robert L H Clements; David J Hayes; Brendan Eshpeter; Andrew J Greenshaw
Journal:  Psychopharmacology (Berl)       Date:  2005-03-03       Impact factor: 4.530

8.  Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion.

Authors:  Minoru Narita; Keisuke Mizuo; Hirokazu Mizoguchi; Mamoru Sakata; Michiko Narita; Leon F Tseng; Tsutomu Suzuki
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

9.  Neuropharmacological evidence for the role of dopamine in ventral pallidum self-stimulation.

Authors:  G Panagis; C Spyraki
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

10.  Differential susceptibility to ethanol and amphetamine sensitization in dopamine D3 receptor-deficient mice.

Authors:  Sarah Jane Harrison; José N Nobrega
Journal:  Psychopharmacology (Berl)       Date:  2008-12-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.